Zevorcabtagene autoleucel

DB17266InvestigationalCell transplant therapies

Zevorcabtagene autoleucel: Overview.

Mechanism: Pharmacologically active on Tumor necrosis factor receptor superfamily member 17
Curator reviewed
Also known as: Zevor-cel
Code names: CT053

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Zevorcabtagene autoleucel, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.